HCC-derived exosomes can effectively activate dendritic cells (DCs) due to their ability to carry HCC antigens [37], while DC-derived exosomes (DEXs) can potentiate anti-tumor immune responses against HCC by contributing to the activation of CD8+ T cells and reshaping the TME [38,39,40]. Here, CD8A is linked to hepatocellular carcinoma.